Dr Reddy's up 2% after subsidiary collaborates with COYA for ALS drug
Dr Reddy’s will make an upfront payment of USD 7.5 million to Coya.
Source: moneycontrol.com
Coya 302 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Coya 302. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Coya 302 Today - Breaking & Trending Today
Coya Therapeutics licenses Dr. Reddy's Abatacept for COYA 302 development
Coya will pay a one-time non-refundable upfront fee to Dr Reddy's, and will also owe tiered milestone payments to the company
Source: livemint.com